The progress and the existing problems and countermeasures of TB drug resistance testing technology

Abstract

Abstract: TB drug resistance testing technology research has made significant progress, but still cannot meet the needs of clinical diagnosis and treatment, and prevention and control. Some new drug susceptibility testing technology including molecular biology and bacteriology is more rapid and sensitive than the traditional detection method, but all kinds of new tools have some problems in clinical application. In this review, the advantages and disadvantages of these new technologies are presented and the potential countermeasures and the advancements are put forward, so as to improve the promotion and application of the new technologies.

Key words: Tuberculosis, Drug resistance, bacterial, Microbial sensitivity tests

HU Zhong-yi. The progress and the existing problems and countermeasures of TB drug resistance testing technology[J]. Chinese Journal of Antituberculosis, 2013, 35(11): 865-867.

References

［1］Wilson ML. Rapid diagnosis of Mycobacterium tuberculosis infection and drug susceptibility testing. Arch Pathol Lab Med,2013,137（6）:812-819.
［2］McNerney R, Maeurer M, Abubakar I,et al. Tuberculosis diagnostics and biomarkers: needs,challenges,recent advances,and opportunities.J Infect Dis,2012,205 Suppl 2:S147-S158.
［3］van Klingeren B, Dessens-Kroon M, van der Laan T,et al.Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method.J Clin Microbiol, 2007, 45(8):2662-2668.
［4］王洁,陆俊梅,黄晓辰,等.微量MIC检测判断结核分枝杆菌药敏的方法学研究.中华检验医学杂志，2010，33（4）：315-319.
［5］Zumla A, Raviglione M, Hafner R,et al.Tuberculosis. N Engl J Med,2013,368(8):745-755.
［6］Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med,2006,355(15): 1539-1550.
［7］陆俊梅，王洁，黄晓辰，等.显微镜观察药物敏感性检测技术在痰标本直接药敏试验中的应用.中华预防医学杂志,2011，45（1）:21-25.
［8］Cui Z, Wang J, Zhu C,et al.Evaluation of a novel biphasic culture medium for recovery of mycobacteria: a multi-center study. PLoS One，2012,7(4):e36331.
［9］Minion J, Pai M. Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: updated meta-analysis. Int J Tuberc Lung Dis,2010, 14(8):941-951.
［10］胡忠义.噬菌体生物扩增法检测结核分枝杆菌及其耐药性方法评价．中华检验医学杂志，2007，30（7）：821-823.
［11］Huang WL, Chi TL, Wu MH, et al. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol,2011,49(7):2502-2508.
［12］菅记涌，王嫩寒，易俊莉，等.MTBDR plus方法快速检测北京地区临床结核分枝杆菌分离株利福平和异烟肼耐药性效果评价.中国防痨杂志，2010,32(10):611-614.
［13］Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay.J Clin Microbiol,2010,48(7):2495-2501.
［14］Boehme CC, Nabeta P, Hillemann D,et al.Rapid molecular detection of tuberculosis and rifampin resistance.N Engl J Med,2010,363(11):1005-1015.
［15］张俊仙,吴雪琼,阳幼荣，等.应用基因芯片方法检测结核分枝杆菌利福平和异烟肼的耐药性.中国防痨杂志,2011,33(10):680-685.
［16］周杨,欧喜超,乐军,等.基因芯片诊断耐多药结核病的临床多中心研究.中华检验医学杂志，2011,34(9)：793-799.
［17］Guo Q, Zheng RJ, Zhu CT,et al. Pyrosequencing for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. Int J Tuberc Lung Dis，2013，17(8)：1008-1013.
［18］郑瑞娟，秦莲花，周燕，等.焦磷酸测序技术检测结核分枝杆菌四种药物耐药性. 中华检验医学杂志，2011,34(2)：115-120.

[1]	LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li. Study on the relationship of stigma and social support of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
[2]	Academic Working Committee of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of fixed-dose combination formulations [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 885-893.
[3]	JIN Hong-jian. The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902.
[4]	ZHANG Can-you, XIA Hui, CHENG Jun. Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909.
[5]	ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915.
[6]	LIU Er-yong, WANG Qian, ZHOU Lin, ZHANG Guo-qin, ZHANG Xiu-lei, MA Yong-cheng, YANG Shu-min, WANG Cui, MENG Qing-lin, CHEN Ming-ting, LIN Ming-gui, TU De-hua.. Analysis of diagnostic quality of pulmonary tuberculosis with negative etiology in some areas of China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 916-920.
[7]	MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925.
[8]	WANG Qian, ZHOU Lin, LIU Er-yong, ZHAO Yan-lin, LI Tao, CHEN Ming-ting, YANG Li-jia, WANG Jia.. A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 926-930.
[9]	LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936.
[10]	LI Yun-kui, HE Jin-ge, SU Qian, LI Ting, LI Jing, GAO Wen-feng, YANG Wen, MAO Guang-yu. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 937-941.
[11]	SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947.
[12]	DENG Ya-li, ZHANG Tian-hua, LIU Wei-ping, ZHANG Hong-wei, MA Yu, LI Peng.. Temporal and spatial clustering analysis of pulmonary tuberculosis incidence in Shaanxi Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 948-955.
[13]	DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961.
[14]	MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972.
[15]	NAN Hai, ZHANG Yun, YANG Xin-ting, DUAN Hong-fei. Meta-analysis on the diagnostic value of GeneXpert MTB/RIF for bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 973-980.